Reuters Stock Buzz Powered by SocialPicks Logo_divider Logo_thomsonreuters Bg_dots_d1
   Sign Up   |   Log In   |   What is Reuters Stock Buzz?   |   FAQ
6 pts

Opinion on  Dendreon Corp (DNDN)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
Like the Playoffs-now I need help from others

Feb 19, 2008 07:25 AM UTC
Staplesnow
Return Risk
-2.05% LOW
Analyst
This pick is about:   DNDN
Rating:   Positive   $5.9 (02/19/08)
Gain/Loss:   -3.00% in 191 days
Target:   $25.00 (+323.73%) in > one year

Recent News  

DNDN...Dendreon.  If you haven't heard or read something about this stock recently, yo are reading the wrong pages, I guess.

This shotup to mid 20's from 5 or 6 dollars after it was approved by the FDA advisory panel somewhat unanimously.  this was about a year ago and again it shows my lack of knowledge, or OK greed at the time, not to get out with a nice little profit.

 

any other newbies, don't make this mistake.  I read the story in the wee hours of the night like now and put in a market order (I know some of you are screaming already) as I left for a doctors appointment.  On my way home at 10:15, I got an alert that my 200 shares went thru at....$18.00 a share.  I was like...what?  Lesson learned and not forgotten.  So Stock did go to 25, could have made a profit, but was so angry about market order I got greedy.  Well FDA did not take the advice of its panel and sent them the dreaded letter.  This stock got shorted so much so quick that I recall reading that people could not find shares anywhere for sale to short.  so since then, I have remained at the 5 or 6 dollar level, waiting.  OK, it stinks for me, but without getting on a soap box, what about the poor guys with prostate cancer who have an automatic death sentence anyway.  why should they suffer and be cheated.

 

Well it turns out they just finished a Congressional inquiry with no action taken in which I doubled my position, hoping for a pop.  The pop never came yet.  I am not selling this until the cows come home with a letter saying give it up!.  This is a good company, a good drug, a bad stock right now.Reports of favoritism on the FDA panel with 2 people having interests in other drug companies working on a similar drug were not enough for a Congressional inquiry.  so now its back to the FDA waiting game as Dendreon as fulfilled its FDA request for reconsideration and it all looks extremely good.  I cannot see any problem getting in small at this price and watching it.  Purely speculative, but as speculative goes, I like this stocks chances

 

time will tell....until than

 

Staples



SocialPicks Sentiment on DNDN:

Dendreon Corp (DNDN)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
70.0%
Top:
50.0%


Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



 



Latest Picks by Billy Staples
Symbol SP Sentiment Rating Return Since
AAPL Positive -3.61% 07/09/08
DEO Positive -11.82% 02/19/08
AMX Positive -15.58% 02/19/08
ZGEN N/A Positive -11.16% 02/19/08
KOL Positive +7.29% 02/19/08

View All >